Lapatinib 250 mg Tablets

Get a Price/Quote

MOQ : 100 Packs

Lapatinib 250 mg Tablets Specification

Indication
Breast cancer, usually in combination with other therapies for HER2-positive advanced or metastatic breast cancer

Salt Composition
Lapatinib Ditosylate 250 mg

Dosage Form
Film-coated tablet

Enzyme Types
Not applicable (synthetic kinase inhibitor)

Feature
Oral administration; targeted HER2/EGFR dual tyrosine kinase inhibitor

Ingredients
Active: Lapatinib Ditosylate; Excipients: as per standard pharmaceutical formulation

Application
Pharmaceutical, Antineoplastic agent

Physical Color/Texture
Light yellow, round, film-coated tablets

Storage Instructions
Store below 30C, protect from light and moisture

Shelf Life
24-36 months (as per packaging)

Prescription Status
Prescription-only medicine

Appearance
Round, film-coated, yellow tablet

Route of Administration
Oral

Storage Conditions
Keep container tightly closed; store at controlled room temperature

Pack Size
Available in strips of 10 or bottle packs (subject to manufacturer)

Regulatory Status
Approved by relevant drug regulatory authorities

Strength
250 mg per tablet

Therapeutic Class
Anticancer, targeted therapy

Caution
To be used only under medical supervision; avoid during pregnancy unless prescribed

Lapatinib 250 mg Tablets Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Lapatinib 250 mg Tablets

Purchase the outstanding Lapatinib 250 mg Tablets, a noteworthy targeted anticancer therapy. Formulated with the noble intent to support patients with HER2-positive advanced or metastatic breast cancer, this prescription-only medicine offers rigorous efficacy as a dual tyrosine kinase inhibitor acting on HER2 and EGFR. You'll find each round, film-coated, yellow tablet contains 250 mg Lapatinib Ditosylate for precise dosing. We offer flexible pack sizes, including strips of 10 or bottle packs. Use is strictly under medical supervision. Find peace of mind, knowing this product is duly approved by regulatory authorities.

Lapatinib 250 mg Tablets: Targeted Therapy for HER2-Positive Breast Cancer

Lapatinib 250 mg Tablets are specifically indicated for the treatment of HER2-positive advanced or metastatic breast cancer, typically in combination with other therapies. Suitable for adult patients, these tablets deliver outstanding efficacy due to their dual tyrosine kinase inhibitor action. Special features include convenient oral administration and targeted action, offering a noble approach for tailored cancer treatment. Always consult a healthcare professional to ensure appropriate use and maximize clinical benefits.

Packaging, Sample Policy, and Purchase Order Details for Lapatinib 250 mg Tablets

We offer Lapatinib 250 mg Tablets in strips of 10 or bottle packs, depending on the manufacturer. Each purchase order is processed efficiently, ensuring prompt delivery. Secure packaging preserves the product's stability, with clear instructions to store below 30C and protect from light and moisture. Sample policies and payment terms can be discussed upon inquiry, providing ease and transparency throughout your purchase process.

FAQ's of Lapatinib 250 mg Tablets:

Q: How should Lapatinib 250 mg Tablets be used?

A: Lapatinib 250 mg Tablets should be taken orally, exactly as prescribed by a healthcare professional. Dosage and administration may vary depending on individual treatment plans and in combination with other therapies.

Q: What specific condition is Lapatinib 250 mg Tablets indicated for?

A: Lapatinib 250 mg Tablets are indicated for the treatment of HER2-positive advanced or metastatic breast cancer, usually combined with other therapeutic agents.

Q: When should Lapatinib 250 mg Tablets be avoided?

A: These tablets should be avoided during pregnancy, unless specifically directed by a doctor, and must only be used under strict medical supervision.

Q: Where can I find packaging information for Lapatinib 250 mg Tablets?

A: Packaging is available in strips of 10 or bottle packs, subject to manufacturer availability; always refer to the packaging for specific details on storage and expiry.

Q: What are the notable benefits of using Lapatinib 250 mg Tablets?

A: Lapatinib 250 mg Tablets deliver targeted therapy for HER2-positive cancers, offering a dual tyrosine kinase inhibitor action, which helps inhibit cancer cell growth more specifically and effectively.

Q: How do I proceed with a purchase or sample request?

A: You can initiate a purchase order or request sample policy details through your supplier or authorized trader. Payment terms and order specifics will be provided upon inquiry.

Tell us about your requirement